GLP-1s and Specialty Drugs Drove Major Cost Pressures for Employer Health Plans in 2025 Biosimilar Adoption Is Rising but Still Falling Short of Savings Potential Plan Ahead: Don't Run Out of Medications This Holiday Season RxConnection Congratulates Our Newlywed Colleagues...
GLP-1s Approved for Alzheimer's Understanding the Xolair Biosimilar National Stress Awareness Month Celebrating Arbor Day!...
GLP-1s Approved for Alzheimer's Understanding the Xolair Biosimilar National Stress Awareness Month Celebrating Arbor Day!...
Wegovy Newest Indication Approval for MASH Migraine Treatment Sees 2 New Drug Approvals in 2025 One Big Beautiful Bill End of Summer Wrap Up...
GLP-1s Approved for Alzheimer's Understanding the Xolair Biosimilar National Stress Awareness Month Celebrating Arbor Day!...
GLP-1s Approved for Alzheimer's Understanding the Xolair Biosimilar National Stress Awareness Month Celebrating Arbor Day!...
GLP-1s Approved for Alzheimer's Understanding the Xolair Biosimilar National Stress Awareness Month Celebrating Arbor Day!...
GLP-1s Approved for Alzheimer's Understanding the Xolair Biosimilar National Stress Awareness Month Celebrating Arbor Day!...
GLP-1s Approved for Alzheimer's Understanding the Xolair Biosimilar National Stress Awareness Month Celebrating Arbor Day!...
FDA Approves New Drug for the Treatment of NASH FDA Approves First Interchangeable Biosimilars to Prolia and Xgeva April Recognizes National Infertility Awareness Week Easter Weekend and Family Time...